Copyright Reports & Markets. All rights reserved.

Global Tissue-Based Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Tissue-Based Diagnostics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Immunohistochemistry (IHC)
    • 1.4.3 In Situ Hybridization (ISH)
    • 1.4.4 Digital Pathology and Workflow Management
    • 1.4.5 Special Staining
  • 1.5 Market by Application
    • 1.5.1 Global Tissue-Based Diagnostics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Research Laboratories
    • 1.5.4 Pharmaceutical Companies
    • 1.5.5 Contract Research Organizations
    • 1.5.6 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Tissue-Based Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Tissue-Based Diagnostics Growth Trends by Regions
    • 2.2.1 Tissue-Based Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Tissue-Based Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Tissue-Based Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Tissue-Based Diagnostics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Tissue-Based Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Tissue-Based Diagnostics Players by Market Size
    • 3.1.1 Global Top Tissue-Based Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Tissue-Based Diagnostics Market Concentration Ratio
    • 3.2.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2019
  • 3.3 Tissue-Based Diagnostics Key Players Head office and Area Served
  • 3.4 Key Players Tissue-Based Diagnostics Product Solution and Service
  • 3.5 Date of Enter into Tissue-Based Diagnostics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Tissue-Based Diagnostics Market Size by Application (2015-2020)
  • 5.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Tissue-Based Diagnostics Market Size (2015-2020)
  • 6.2 Tissue-Based Diagnostics Key Players in North America (2019-2020)
  • 6.3 North America Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 6.4 North America Tissue-Based Diagnostics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Tissue-Based Diagnostics Market Size (2015-2020)
  • 7.2 Tissue-Based Diagnostics Key Players in Europe (2019-2020)
  • 7.3 Europe Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 7.4 Europe Tissue-Based Diagnostics Market Size by Application (2015-2020)

8 China

  • 8.1 China Tissue-Based Diagnostics Market Size (2015-2020)
  • 8.2 Tissue-Based Diagnostics Key Players in China (2019-2020)
  • 8.3 China Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 8.4 China Tissue-Based Diagnostics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Tissue-Based Diagnostics Market Size (2015-2020)
  • 9.2 Tissue-Based Diagnostics Key Players in Japan (2019-2020)
  • 9.3 Japan Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 9.4 Japan Tissue-Based Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Tissue-Based Diagnostics Market Size (2015-2020)
  • 10.2 Tissue-Based Diagnostics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Tissue-Based Diagnostics Market Size by Application (2015-2020)

11 India

  • 11.1 India Tissue-Based Diagnostics Market Size (2015-2020)
  • 11.2 Tissue-Based Diagnostics Key Players in India (2019-2020)
  • 11.3 India Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 11.4 India Tissue-Based Diagnostics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Tissue-Based Diagnostics Market Size (2015-2020)
  • 12.2 Tissue-Based Diagnostics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Tissue-Based Diagnostics Market Size by Type (2015-2020)
  • 12.4 Central & South America Tissue-Based Diagnostics Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Roche
    • 13.1.1 Roche Company Details
    • 13.1.2 Roche Business Overview
    • 13.1.3 Roche Tissue-Based Diagnostics Introduction
    • 13.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2015-2020))
    • 13.1.5 Roche Recent Development
  • 13.2 Danaher
    • 13.2.1 Danaher Company Details
    • 13.2.2 Danaher Business Overview
    • 13.2.3 Danaher Tissue-Based Diagnostics Introduction
    • 13.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.2.5 Danaher Recent Development
  • 13.3 Thermo Fisher Scientific
    • 13.3.1 Thermo Fisher Scientific Company Details
    • 13.3.2 Thermo Fisher Scientific Business Overview
    • 13.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction
    • 13.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.3.5 Thermo Fisher Scientific Recent Development
  • 13.4 Abbott
    • 13.4.1 Abbott Company Details
    • 13.4.2 Abbott Business Overview
    • 13.4.3 Abbott Tissue-Based Diagnostics Introduction
    • 13.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.4.5 Abbott Recent Development
  • 13.5 Agilent Technologies
    • 13.5.1 Agilent Technologies Company Details
    • 13.5.2 Agilent Technologies Business Overview
    • 13.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction
    • 13.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.5.5 Agilent Technologies Recent Development
  • 13.6 ABCAM
    • 13.6.1 ABCAM Company Details
    • 13.6.2 ABCAM Business Overview
    • 13.6.3 ABCAM Tissue-Based Diagnostics Introduction
    • 13.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.6.5 ABCAM Recent Development
  • 13.7 Merck
    • 13.7.1 Merck Company Details
    • 13.7.2 Merck Business Overview
    • 13.7.3 Merck Tissue-Based Diagnostics Introduction
    • 13.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.7.5 Merck Recent Development
  • 13.8 BD
    • 13.8.1 BD Company Details
    • 13.8.2 BD Business Overview
    • 13.8.3 BD Tissue-Based Diagnostics Introduction
    • 13.8.4 BD Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.8.5 BD Recent Development
  • 13.9 Hologic
    • 13.9.1 Hologic Company Details
    • 13.9.2 Hologic Business Overview
    • 13.9.3 Hologic Tissue-Based Diagnostics Introduction
    • 13.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.9.5 Hologic Recent Development
  • 13.10 Bio Rad
    • 13.10.1 Bio Rad Company Details
    • 13.10.2 Bio Rad Business Overview
    • 13.10.3 Bio Rad Tissue-Based Diagnostics Introduction
    • 13.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2015-2020)
    • 13.10.5 Bio Rad Recent Development

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Tissue-Based Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tissue-Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Roche
    Danaher
    Thermo Fisher Scientific
    Abbott
    Agilent Technologies
    ABCAM
    Merck
    BD
    Hologic
    Bio Rad

    Market segment by Type, the product can be split into
    Immunohistochemistry (IHC)
    In Situ Hybridization (ISH)
    Digital Pathology and Workflow Management
    Special Staining
    Market segment by Application, split into
    Hospitals
    Research Laboratories
    Pharmaceutical Companies
    Contract Research Organizations
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
    Buy now